Small Intestinal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Small Intestinal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas [Phase 1]
This entry reports a Phase 1 clinical trial of a GUCY2C prime-boost vaccination for advanced colorectal cancer and small intestinal adenocar…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers [Phase 2]
A Phase 2 clinical trial studying ramucirumab with paclitaxel or FOLFIRI for advanced small intestinal adenocarcinoma is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors [Phase 2]
Phase 2 clinical trial update evaluating cobimetinib in combination with atezolizumab in participants with advanced or refractory rare tumor…
-
CLINICAL_TRIALS withdrawal · 2024-08-19Clinical Trial Update: Data Collection of PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy Routine Care Procedures (GPS Study)
A Medtronic-sponsored clinical trial evaluating PillCam SB3 capsule endoscopy and device-assisted enteroscopy for routine care has been with…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma [Phase 2]
Phase 2 trial assessing safety and efficacy of avelumab in small intestinal adenocarcinoma has been terminated with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma [Phase 2]
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in advanced ampulla of Vater and small intestinal adenocarcinoma has completed w…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating pembrolizumab for metastatic or unresectable small intestinal adenocarcinoma, with results posted in 2020.